---
company: Hims & Hers Health, Inc.
ticker: HIMS
form: 8-K
filed: 2026-08-10
accession: 0001773751-26-000161
source: https://www.sec.gov/Archives/edgar/data/1773751/000177375126000161/
---

# Hims & Hers Health (HIMS) earnings release, August 10, 2026

Hims & Hers Health, Inc. (HIMS) · Form 8-K, Item 2.02 · Filed 2026-08-10 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1773751/000177375126000161/)

Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results

Revenue of approximately $753 million, up 38% year-over-year in Q2 2026

Subscribers grew to nearly 2.9 million, up 19% year-over-year in Q2 2026

Raises full year 2026 revenue guidance to a range of $3.1 billion to $3.3 billion and updates Adjusted EBITDA guidance to a range of $275 million to $325 million

SAN FRANCISCO, August 10, 2026 – Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading global health and wellness platform, today announced financial results for the second quarter ended June 30, 2026.

“Hims & Hers is delivering a world-class health experience at a global scale and a reasonable price for the nearly 3 million people who rely on us for access to care. We’re proving, quarter after quarter, that helping people feel great and delivering strong results aren’t mutually exclusive,” said Andrew Dudum, co-founder and CEO. “We have never been better positioned to move faster or go further than we are today. As we rebuild the consumer health experience from the ground up with a doctor-led AI clinical engine, the depth and breadth of our relationships with customers worldwide has never been greater. Every quarter, we raise the standard for what care should look like everywhere: high-quality, personal, and accessible.”

“Our second quarter results were defined by a significant re-acceleration in our growth profile and the continued expanding reach of our platform,” said Yemi Okupe, Chief Financial Officer. “Domestic revenue growth accelerated to 16% year-over-year, and our international business grew more than 17-fold, strengthened by the close of our Eucalyptus acquisition in June. We expect our domestic business to continue accelerating through the second half of the year. This momentum, combined with the meaningful efficiencies we're generating from our investments in AI and technology, positions us to make access to high touch, comprehensive care more affordable for our customers while also significantly expanding our reach internationally. As a result, we are raising our 2026 revenue outlook and building increased conviction in our 2030 targets of at least $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA.”

Key Business Metrics

(In Thousands, Except for Monthly Revenue per Average Subscriber, Unaudited)

Revenue

(In Thousands, Unaudited)

Second Quarter 2026 Financial Highlights

• Revenue was $753.2 million for the second quarter of 2026 compared to $544.8 million for the second quarter of 2025, an increase of 38% year-over-year.

• Gross margin was 64% for the second quarter of 2026 compared to 76% for the second quarter of 2025.

• Net loss was $86.3 million for the second quarter of 2026 compared to net income of $42.5 million for the second quarter of 2025.

• Adjusted EBITDA was $60.3 million for the second quarter of 2026 compared to $82.2 million for the second quarter of 2025.

• Net cash (used in) operating activities was

$(35.9) million for the second quarter of 2026 compared to $(19.1) million for the second quarter of 2025.

• Free Cash Flow was $(68.2) million for the second quarter of 2026 compared to $(69.4) million for the second quarter of 2025.

Reconciliations of Adjusted EBITDA and Free Cash Flow, non-GAAP measures, to net (loss) income and net cash (used in) provided by operating activities, respectively, their most comparable financial measures under generally accepted accounting principles in the United States (“U.S. GAAP”), have been provided in this press release in the accompanying tables. Additional information about Adjusted EBITDA and Free Cash Flow is also included below under the heading “Non-GAAP Financial Measures”.

Financial Outlook

Hims & Hers is providing the following guidance:

For the third quarter 2026, we expect:

• Revenue of $880 million to $900 million.

• Adjusted EBITDA of $75 million to $95 million, reflecting an Adjusted EBITDA margin of 9% to 11%.

For the full year 2026, we expect:

• Revenue of $3.1 billion to $3.3 billion.

• Adjusted EBITDA of $275 million to $325 million, reflecting an Adjusted EBITDA margin of 9% to 10%.

The guidance provided above constitutes forward-looking statements and actual results may differ materially. Refer to the “Cautionary Note Regarding Forward-Looking Statements” safe harbor section below for information on the factors that could cause our actual results to differ materially from these forward-looking statements.

We have relied upon the exception in Item 10(e)(1)(i)(B) of Regulation S-K and have not reconciled forward-looking Adjusted EBITDA to its most directly comparable U.S. GAAP measure, net income or loss, because we cannot predict with reasonable certainty the ultimate outcome of certain components of such reconciliations, including market-related assumptions that are not within our control, or others that may arise, without unreasonable effort. For these reasons, we are unable to assess the probable significance of the unavailable information, which could materially impact the amount of future net income or loss. See “Non-GAAP Financial Measures” for additional important information regarding Adjusted EBITDA.

Conference Call

Hims & Hers will host a conference call to review the second quarter 2026 results on August 10, 2026, at 5:00 p.m. ET. The conference call can be accessed by dialing +1 (833) 461-5787 for U.S. participants and +1 (585) 542-9983 for international participants, and referencing conference ID #782 611 911. A live audio webcast will be available online at investors.hims.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same link.

About Hims & Hers Health, Inc.

Hims & Hers is the leading global health and wellness platform on a mission to help the world feel great through the power of better health.... (truncated)why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the Company provides access to personalized care designed for results.

For more information, please visit investors.hims.com.

Cautionary Note Regarding Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “estimates,” “anticipates,” “expects,” “intends,” “plans,” “assumes,” “may,” “will,” “likely,” “potential,” “projects,” “predicts,” “continue,” “goal,” “strategy,” “future,” “forecast,” “target,” “outlook,” “opportunity,” “confidence,” “foundation,” “groundwork,” or “should,” or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, any statements relating to our financial outlook and guidance, including our mission to drive top-line revenue growth and profitability and our ability to attain our 2026 and long-term financial and operational targets; our expected future financial and business performance, including with respect to the Hims & Hers platform, our marketing campaigns, investments in innovation, the solutions accessible on our platform, the markets accessible on our platform, and our infrastructure, and the underlying assumptions with respect to the foregoing; potential strategic investments, partnerships, or collaborations, and the expected timing or outcome of any such investments, partnerships, or collaborations; statements relating to events and trends relevant to us, including with respect to our regulatory environment, financial condition, results of operations, short- and long-term business operations, objectives, strategy, and financial needs; expectations regarding our mobile applications, market acceptance, user experience, customer retention, brand development, our ability to invest and generate a return on any such investment, customer acquisition costs, operating efficiencies and leverage (including our fulfillment capabilities), the effect of any pricing decisions; changes in our product or offering mix, and the timing and market acceptance of any new products or offerings; the timing and anticipated effect of any pending or recently completed acquisitions; the success and utility of our business model; our market opportunity; our ability to scale our business and expand internationally; the growth of certain of our specialties; our ability to innovate on and expand the scope of our offerings and experiences, including through the use of diagnostics, data analytics and artificial intelligence; our ability to reinvest into the customer experience; and our ability to comply with the extensive, complex and evolving legal and regulatory requirements applicable to our business, including without limitation state and federal healthcare, privacy and consumer protection laws and regulations, and the effect or outcome of litigation or governmental actions or statements in relation to any such legal and regulatory requirements. These statements are based on management’s current expectations, but actual results may differ materially due to various factors.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, the forward-looking statements contained in this press release are based on our current expectations, assumptions, and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in the Risk Factors and other sections of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and other current and periodic reports we file from time to time with the Securities and Exchange Commission (the “Commission”).

Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The forward-looking statements contained in this press release are made only as of August 10, 2026. We undertake no obligation (and expressly disclaim any obligation) to update or revise any forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and developments in the industry in which we operate may differ materially from those made in or suggested by the forward-looking statements contained in reports we have filed or will file with the Commission, including our most... (truncated) 10-K, and other current and periodic reports we file from time to time. In addition, even if our results of operations, financial condition and liquidity, and developments in the industry in which we operate are consistent with the forward-looking statements contained in such reports, those results or developments may not be indicative of results or developments in subsequent periods.

Key Business Metrics

Our consolidated revenue primarily comprises online sales of health and wellness products through our websites and mobile applications, including prescription and non-prescription products, as well as services, primarily consisting of medical consultation services, membership-based access, post-consultation service support, and delivery of laboratory testing results, as applicable. Our online sales are net of refunds, credits, and chargebacks, and include revenue recognition adjustments recorded pursuant to U.S. GAAP, primarily relating to deferred revenue and returns reserve. A substantial majority of our online sales are subscription-based, where customers agree to be billed on a recurring basis to have products and services automatically delivered to them. This revenue also includes sales from customers who have made one-time purchases.

“United States Revenue” represents the sales of products and services by our consolidated legal entities operating within jurisdictions located inside of the United States.

“Rest of the World Revenue” represents the sales of products and services by our consolidated legal entities operating within jurisdictions located outside of the United States.

“Subscribers” are customers who have one or more “Subscriptions” pursuant to which they have agreed to be automatically billed on a recurring basis at a defined cadence. The Subscription billing cadence is typically defined as a number of days (for example, billed every 30 days or every 90 days), which are excluded from our reporting when payment has not occurred at the contracted billing cadence. Subscribers can cancel or snooze Subscriptions in between billing periods to stop receiving additional products and/or services and can reactivate Subscriptions to continue receiving additional products and/or services. Customers who have made one-time purchases are not considered Subscribers.

“Monthly Revenue per Average Subscriber” is defined as total revenue divided by “Average Subscribers”, which amount is then further divided by the number of months in a period.

“Average Subscribers” are calculated as the sum of the Subscribers at the beginning and end of a given period divided by 2.

## Financial statements

### Income Statement (Three Months Ended June 30, — (In Thousands, Unaudited) (in thousands))

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Three Months Ended June 30, – % Change | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 | Six Months Ended June 30, – % Change |
|---|---:|---:|---:|---:|---:|---:|
| United States Revenue | 621,830 | 537,286 | 16.0% | 1,151,739 | 1,115,978 | 3.0% |
| Rest of the World Revenue | 131,384 | 7,547 | 1641.0% | 209,579 | 14,865 | 1310.0% |
| Total revenue | 753,214 | 544,833 | 38.0% | 1,361,318 | 1,130,843 | 20.0% |

### Income Statement (Three Months Ended June 30, — (In Thousands, Except Share and Per Share Data, Unaudited))

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 |
|---|---:|---:|---:|---:|
| Revenue | 753,214 | 544,833 | 1,361,318 | 1,130,843 |
| Cost of revenue | 272,411 | 128,637 | 483,728 | 283,958 |
| Gross profit | 480,803 | 416,196 | 877,590 | 846,885 |
| Gross margin % | 64.0% | 76 | 64.0% | 75 |
| Operating expenses:(1) | Marketing | 262,236 | 217,862 | 484,239 | 449,097 |
| Operating expenses:(1) | Operations and support | 95,481 | 66,490 | 191,984 | 129,523 |
| Operating expenses:(1) | Technology and development | 54,901 | 37,848 | 101,837 | 67,762 |
| Operating expenses:(1) | General and administrative | 165,377 | 67,273 | 275,045 | 115,883 |
| Operating expenses:(1) | Total operating expenses | 577,995 | 389,473 | 1,053,105 | 762,265 |
| Operating expenses:(1) | (Loss) income from operations | -97,192 | 26,723 | -175,515 | 84,620 |
| Other income (expense): | Change in fair value of equity securities | 4,737 |  | -4,945 |  |
| Other income (expense): | Change in fair value of liabilities | -4,223 |  | -21,869 |  |
| Other income (expense): | Other income, net | 4,045 | 6,130 | 8,145 | 8,728 |
| Other income (expense): | Total other income (expense), net | 4,559 | 6,130 | -18,669 | 8,728 |
| Other income (expense): | (Loss) income before income taxes | -92,633 | 32,853 | -194,184 | 93,348 |
| Other income (expense): | Benefit from (provision for) income taxes | 6,343 | 9,652 | 15,779 | -1,358 |
| Other income (expense): | Net (loss) income | -86,290 | 42,505 | -178,405 | 91,990 |
| Other income (expense): | Other comprehensive (loss) income | -41,632 | 986 | -48,331 | 1,146 |
| Other income (expense): | Total comprehensive (loss) income | -127,922 | 43,491 | -226,736 | 93,136 |
| Net (loss) income per share attributable to common stockholders: | Basic | -0.37 | 0.19 | -0.78 | 0.41 |
| Net (loss) income per share attributable to common stockholders: | Diluted | -0.37 | 0.17 | -0.78 | 0.37 |
| Weighted average shares outstanding: | Basic | 231,746,126 | 224,373,375 | 230,061,076 | 223,187,936 |
| Weighted average shares outstanding: | Diluted | 231,746,126 | 256,779,292 | 230,061,076 | 251,894,929 |

### Income Statement (Three Months Ended June 30, — (In Thousands, Unaudited) (in thousands))

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 |
|---|---:|---:|---:|---:|
| Revenue | 753,214 | 544,833 | 1,361,318 | 1,130,843 |
| Net (loss) income | -86,290 | 42,505 | -178,405 | 91,990 |
| Legal contingencies | 47,500 |  | 62,500 |  |
| Stock-based compensation | 42,116 | 35,726 | 78,978 | 60,584 |
| Depreciation and amortization | 29,477 | 10,465 | 51,430 | 18,741 |
| Acquisition and transaction-related costs | 28,835 | 6,231 | 42,201 | 6,255 |
| Restructuring and other related charges | 4,626 |  | 38,114 |  |
| Change in fair value of liabilities | 4,223 |  | 21,869 |  |
| Payroll tax expense related to stock-based compensation | 2,022 | 3,078 | 4,889 | 3,078 |
| Impairment of long-lived assets | 1,148 |  | 1,148 |  |
| Interest income and expense, net | -2,254 | -6,117 | -7,287 | -8,713 |
| Change in fair value of equity securities | -4,737 |  | 4,945 |  |
| (Benefit from) provision for income taxes | -6,343 | -9,652 | -15,779 | 1,358 |
| Adjusted EBITDA | 60,323 | 82,236 | 104,603 | 173,293 |
| Net (loss) income as a % of revenue | -11 | 8 | -13 | 8 |
| Adjusted EBITDA margin | 8 | 15 | 8 | 15 |

### Income Statement (Three Months Ended June 30, — (In Thousands, Unaudited) (in thousands))

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 |
|---|---:|---:|---:|---:|
| Revenue | 753,214 | 544,833 | 1,361,318 | 1,130,843 |
| Gross Profit | 480,803 | 416,196 | 877,590 | 846,885 |
| Restructuring and other related charges included within cost of revenue |  |  | 28,462 |  |
| Adjusted Gross Profit | 480,803 | 416,196 | 906,052 | 846,885 |
| Gross margin % | 64 | 76 | 64 | 75 |
| Adjusted gross margin % | 64 | 76 | 67 | 75 |

### Balance Sheet (June 30, 2026 — (In Thousands, Except Share and Per Share Data, Unaudited))

| | June 30, 2026 | December 31, 2025 |
|---|---:|---:|
| Current assets: | Cash and cash equivalents | 609,811 | 228,616 |
| Current assets: | Short-term available-for-sale investments | 231,237 | 348,876 |
| Current assets: | Receivables, net | 375,291 | 32,149 |
| Current assets: | Inventory | 87,781 | 80,128 |
| Current assets: | Prepaid expenses and other current assets | 80,493 | 77,869 |
| Current assets: | Total current assets | 1,384,613 | 767,638 |
| Current assets: | Long-term available-for-sale investments |  | 351,263 |
| Current assets: | Goodwill | 1,101,720 | 278,325 |
| Current assets: | Property, equipment, and software, net | 364,215 | 311,930 |
| Current assets: | Intangible assets, net | 422,809 | 196,116 |
| Current assets: | Operating lease right-of-use assets | 165,565 | 137,046 |
| Current assets: | Deferred tax assets, net | 111,578 | 82,707 |
| Current assets: | Other long-term assets | 78,314 | 29,680 |
| Current assets: | Total assets | 3,628,814 | 2,154,705 |
| Current liabilities: | Accounts payable | 501,297 | 143,278 |
| Current liabilities: | Accrued liabilities | 210,255 | 77,039 |
| Current liabilities: | Deferred revenue | 141,384 | 127,160 |
| Current liabilities: | Deferred acquisition payable | 537,381 | 1,479 |
| Current liabilities: | Earn-out consideration | 81,364 | 50,632 |

### Cash Flow (Six Months Ended June 30, — (In Thousands, Unaudited) (in thousands))

| | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 |
|---|---:|---:|
| Operating activities | Net (loss) income | -178,405 | 91,990 |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | Depreciation and amortization | 51,430 | 18,741 |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | Stock-based compensation | 78,978 | 60,584 |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | Change in fair value of equity securities | 4,945 |  |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | Change in fair value of liabilities | 21,869 |  |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | Net accretion on securities | -338 | -1,060 |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | Benefit from deferred taxes | -23,338 | -10,346 |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | Impairment of long-lived assets | 1,148 |  |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | Amortization of debt discount and issuance costs | 3,656 | 1,047 |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | Non-cash operating lease cost | 9,482 | 4,594 |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | Non-cash acquisition-related costs | 21,311 | 2,985 |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | Non-cash restructuring and other related charges included within cost of revenue | 28,462 |  |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | Non-cash other | 2,511 | -1,315 |
| Changes in operating assets and liabilities: | Receivables, net | -328,987 | -654 |
| Changes in operating assets and liabilities: | Inventory | -14,255 | -77,373 |
| Changes in operating assets and liabilities: | Prepaid expenses and other current assets | 80 | -37,427 |
| Changes in operating assets and liabilities: | Other long-term assets | -30,553 | -10 |
| Changes in operating assets and liabilities: | Accounts payable | 323,795 | 5,146 |
| Changes in operating assets and liabilities: | Accrued liabilities | 89,526 | 11,737 |
| Changes in operating assets and liabilities: | Deferred revenue | 2,960 | 23,132 |
| Changes in operating assets and liabilities: | Earn-out consideration | -7,058 |  |
| Changes in operating assets and liabilities: | Deferred acquisition payable | 472 |  |
| Changes in operating assets and liabilities: | Operating lease liabilities | -4,894 | -1,798 |
| Changes in operating assets and liabilities: | Other long-term liabilities | 620 |  |
| Changes in operating assets and liabilities: | Net cash provided by operating activities | 53,417 | 89,973 |
| Investing activities | Maturities of available-for-sale investments | 116,232 | 60,569 |
| Investing activities | Proceeds from sales of available-for-sale investments | 350,762 |  |
| Investing activities | Purchases of property, equipment, and intangible assets | -55,770 | -101,392 |
| Investing activities | Investment in website development and internal-use software | -12,808 | -7,961 |
| Investing activities | Acquisition of businesses, net of cash acquired | -318,108 | -5,100 |
| Investing activities | Purchases of equity securities | -11,217 |  |
| Investing activities | Net cash provided by (used in) investing activities | 69,091 | -53,884 |
| Financing activities | Proceeds from issuance of convertible senior notes, net of debt discount | 390,425 | 970,000 |
| Financing activities | Purchases of capped calls related to convertible senior notes | -36,748 | -47,800 |
| Financing activities | Proceeds from exercise of vested stock options | 13,030 | 6,497 |
| Financing activities | Payments for taxes related to net share settlement of equity awards | -62,324 | -62,475 |
| Financing activities | Proceeds from employee stock purchase plan | 3,846 | 2,970 |
| Financing activities | Payments for acquisition-related earn-out consideration | -43,682 |  |
| Financing activities | Payments for debt issuance costs | -671 | -3,041 |
| Financing activities | Net cash provided by financing activities | 263,876 | 866,151 |
| Financing activities | Foreign currency effect on cash and cash equivalents | -5,189 | 1,270 |
| Financing activities | Increase in cash, cash equivalents, and restricted cash | 381,195 | 903,510 |
| Financing activities | Cash, cash equivalents, and restricted cash at beginning of period | 228,616 | 221,440 |

### Cash Flow (Three Months Ended June 30, — (In Thousands, Unaudited) (in thousands))

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 |
|---|---:|---:|---:|---:|
| Net cash (used in) provided by operating activities | -35,939 | -19,117 | 53,417 | 89,973 |
| Purchases of property, equipment, and intangible assets in investing activities | -25,926 | -46,065 | -55,770 | -101,392 |
| Investment in website development and internal-use software in investing activities | -6,328 | -4,250 | -12,808 | -7,961 |
| Free Cash Flow | -68,193 | -69,432 | -15,161 | -19,380 |
